Skip to main content
Premium Trial:

Request an Annual Quote

Lucigen Wins $750,000 Phase II SBIR Grant for Gene Mining Technology

NEW YORK, July 11 - Lucigen of Middleton, Wis.announced today that it had been awarded a $750,000 Phase II Small Business Innovation Research grant from the US Department of Energy to commercialize its Single Cell Genomics gene mining technology. The grant is funded through the DOE's Genomes to Life Program.

 

Single Cell Genomics technology allows for the isolation and cloning of genes from a single cell or virus. The technology can be used to find new product sources by mining cells and viruses that can't be cultured in a laboratory, the company said in a statement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.